Irbesartan, a synthetic, nonpeptide antagonist of angiotensin II (Ang II), is primarily utilized as an angiotensin type 1 (AT1) receptor blocker for hypertension treatment (Darwish et al. 2021). The gene discussed is AGT; the disease is hypertensive disorder.